Post-earnings recap
Reported
Wed, Apr 29, 2026
EPS actual
$0.05
EPS est.
$0.06
EPS surprise
-10.71%
1-day move
-2.42%
Bausch + Lomb's earnings report shows a slight miss on EPS expectations, which contributed to a 1.59% drop in stock price. The lack of revenue data and forward guidance may raise concerns among investors about the company's future performance. Management's cautious tone suggests they are aware of the challenges ahead and are focusing on internal efficiencies.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.05 | $0.05 | -10.71% |
| Revenue | N/A | $1.2B | N/A |
Management expressed concerns about the current market conditions impacting performance. They emphasized a commitment to improving operational efficiency.
We are navigating a challenging market environment.
Our focus remains on operational efficiency and cost management.
Bausch + Lomb Corporation (BLCO) operates in the health care sector, focusing on eye health products and surgical devices. With a market cap of $6 billion, the company plays a significant role in the growing demand for eye care solutions as the global population ages.
Last quarter
In Q4 2025, Bausch + Lomb reported an EPS of $0.32, slightly missing the estimate of $0.35. The stock reacted negatively, declining by 0.34% the next day.
Management promises and guidance
EPS beat streak
0Q
EPS beat rate
38%
Avg EPS surprise
-76.66%
Avg 1-day reaction
-3.43%
Analysts are cautiously optimistic about Bausch + Lomb's upcoming earnings, with a consensus EPS of $0.05 and revenue expectations at $1.2 billion. The stock's recent performance has been mixed, leading to uncertainty.
Bull case
If the company can exceed EPS expectations and show strong revenue growth, it could signal a turnaround in performance, boosting investor confidence.
Bear case
Conversely, if the company fails to meet even the low expectations, it could indicate deeper issues, leading to a significant decline in stock price.
Key metrics to watch
EPS
$0.05Earnings per share is a key indicator of profitability, and this quarter's consensus is particularly low, suggesting cautious expectations.
Revenue
$1.2BRevenue figures will provide insight into the company's sales performance and market demand for its products.
The print will turn on these.
Q1
Will the EPS exceed the consensus estimate of $0.05?
A beat on EPS could indicate stronger profitability and boost investor sentiment, while a miss could raise concerns about the company's financial health.
Q2
What are the revenue figures compared to the expected $1.2 billion?
Revenue performance will be crucial in assessing market demand for Bausch + Lomb's products and overall business growth.
—
Est. EPS
$1.52
Est. Rev
$3.6B
Impl. Move
±39.2%
Why consensus could be wrong
The Street may be underestimating Bausch + Lomb's potential for revenue growth driven by new product launches and market expansion.
Supporting evidence
The company's recent focus on cost management could lead to better-than-expected margins.
Options pricing suggests a higher volatility expectation than historical performance, indicating potential for a surprise.
The strong demand for eye care products in aging populations may not be fully reflected in current estimates.
Key risk
If revenue exceeds $1.3 billion, it could challenge the current bearish sentiment and shift market perceptions.
Pre-commit to what would confirm each case.
The market is debating whether Bausch + Lomb can overcome its recent earnings challenges and demonstrate growth in a competitive landscape.
Bull confirmed if
An EPS of $0.10 or higher would confirm the bull case, indicating strong operational performance.
Bear confirmed if
An EPS below $0.02 would confirm the bear case, suggesting ongoing struggles in profitability.
What the market is pricing for the move.
Implied Move
±14.53%
Historical Avg
±3.9%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±40.7% while BLCO has averaged ±3.9% over the last 8 prints — setup is pricing rich.
ATM IV
1.9%
30d HV
34.7%
Smart-money positioning from the most recent 13F filings.
Institutional
11.14%
of float
Insider
87.29%
of float
Holders
123
institutions
Top Holders· as of Jun 2026
Icahn Carl C
3,500,000 sh · $60.7M
0.98%
Flat
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Bausch + Lomb beats expectations, history suggests the stock could see a modest increase, confirming a positive turnaround narrative.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further guidance.
Miss
A miss on earnings could lead to a significant decline, with historical patterns indicating an average drop of around 5.19%.
The lines on the call that would change the story.
Deutsche Bank AG
3,423,046 sh · $59.4M
0.96%
-3.0%
Oaktree Capital Management LP
3,441,042 sh · $59.7M
0.96%
1.7%
Shaw D.E. & Co., Inc.
3,323,021 sh · $57.6M
0.93%
5.5%
Davidson Kempner Capital Management LP
3,158,972 sh · $54.8M
0.88%
43.6%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.